|
PIGY expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.0001000289891E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.7576000038998E-08 |
| Normal-vs-Stage2 |
8.101800E-03 |
| Normal-vs-Stage3 |
1.70680000133316E-08 |
| Normal-vs-Stage4 |
1.26170185410501E-11 |
| Stage1-vs-Stage2 |
2.558400E-01 |
| Stage1-vs-Stage3 |
1.800350E-01 |
| Stage1-vs-Stage4 |
1.457330E-03 |
| Stage2-vs-Stage3 |
5.468000E-02 |
| Stage2-vs-Stage4 |
1.941120E-03 |
| Stage3-vs-Stage4 |
5.903600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.65969518315524E-11 |
| Normal-vs-AfricanAmerican |
1.481080E-03 |
| Normal-vs-Asian |
1.848330E-04 |
| Caucasian-vs-AfricanAmerican |
4.460800E-01 |
| Caucasian-vs-Asian |
1.825180E-01 |
| AfricanAmerican-vs-Asian |
8.549600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80820003414794E-09 |
| Normal-vs-Female |
4.59019999787813E-08 |
| Male-vs-Female |
8.865700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.03750000205005E-08 |
| Normal-vs-Age(41-60Yrs) |
1.34179999999873E-07 |
| Normal-vs-Age(61-80Yrs) |
1.53360000032521E-07 |
| Normal-vs-Age(81-100Yrs) |
7.122300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.739800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.670000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.419400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.006200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.804400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.922600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.167000E-01 |
| Classical-VS-Follicular |
1.302770E-01 |
| Classical-VS-Other |
8.010600E-01 |
| Classical-VS-Normal |
6.8287997478933E-10 |
| Tall-VS-Follicular |
4.575800E-02 |
| Tall-VS-Other |
8.592400E-01 |
| Tall-VS-Normal |
5.21130000041836E-07 |
| Follicular-VS-Other |
5.250200E-01 |
| Follicular-VS-Normal |
1.076440E-03 |
| Other-VS-Normal |
1.337550E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.85419999968006E-07 |
| Normal-vs-N1 |
3.12990000583824E-09 |
| N0-vs-N1 |
1.098110E-02 |
|
|
